A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder

Completed · Phase 3 · Has a placebo group

Conditions studied: Major Depressive Disorder

In brief

This trial is a 14 week, randomized, double-blind, placebo controlled study, to assess the safety and efficacy of aripiprazole as adjunctive treatment to an ongoing antidepressant treatment in patients with Major Depressive Disorder.

Key facts

Study ID

NCT00095758

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

1151

Starts

2004-09-01

Expected to finish

2006-12-01

Last updated by the study team

2026-07-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women, 18-65 years old
• Experienced a Major Depressive Disorder with the current episode of minimally 8 weeks in duration.
• Treatment history of an inadequate response to at least one and no more than three antidepressants.

Where it is running

• Local Institution — Beverly Hills, California, United States
• Local Institution — Burbank, California, United States
• Local Institution — National City, California, United States
• Local Institution — Orange, California, United States
• Local Institution — Pasadena, California, United States
• Local Institution — Denver, Colorado, United States
• Local Institution — Farmington, Connecticut, United States
• Local Institution — Jacksonville, Florida, United States
• Local Institution — Orlando, Florida, United States
• Local Institution — Atlanta, Georgia, United States
• Local Institution — Rockville, Maryland, United States
• Local Institution — Albuquerque, New Mexico, United States
• Local Institution — Brooklyn, New York, United States
• Local Institution — New York, New York, United States
• Local Institution — Cincinnati, Ohio, United States
• Local Institution — Toledo, Ohio, United States
• Local Institution — Portland, Oregon, United States
• Local Institution — Pittsburgh, Pennsylvania, United States
• Local Institution — Memphis, Tennessee, United States
• Local Institution — Dallas, Texas, United States
• Local Institution — Houston, Texas, United States
• Local Institution — Arlington, Virginia, United States
• Local Institution — Herndon, Virginia, United States
• Local Institution — Richmond, Virginia, United States
• Local Institution — Bellevue, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.